Bioorganic and Medicinal Chemistry (2020)
Update date:2022-07-29
Topics: Synthesis Data Analysis Biological Assays Clinical Trials Literature Review Structure-Activity Relationship (SAR) Study Lead Optimization Toxicity and ADME Studies Market Launch Preclinical Testing Scale-Up Synthesis Project Goals and Compound Design Synthesis Planning Regulatory and Intellectual Property Considerations Data Submission and Review
Chen, Wenteng
Liu, Shuangrong
Liu, Xingyu
Pan, Youlu
Shao, Jiaan
The covalent binding nature of irreversible kinase inhibitors potentially increases the severity of “off-target” toxicity. Based on our continual strategy of chemically tuning the Michael addition acceptors, herein, we further explore the relationship amo
View MoreSHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551611
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Luzhou North Chemical Co., Ltd.
Contact:+86-830-2796784;+86-830-2796776
Address:Gaoba, Longmatan District, Luzhou, Sichuan Province
Anhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Guangzhou Reachin Chemical Co., Ltd
Contact:+86-20-37087379 ext.604
Address:A122C-1, Tianyuan Plaza, 401 Tianyuan Rd., Tianhe, Guangzhou, China
Shandong Wanda Organosilicon New Material Co., Ltd
Contact:+86-21-54177116;54302881
Address:R1318 Greenland No. 3 Lane 58 Xinjian East Rd., Minhang
Doi:10.1016/j.tet.2005.11.082
(2006)Doi:10.1134/S1070363207050210
(2007)Doi:10.1039/c39860000037
(1986)Doi:10.1021/acsinfecdis.7b00130
(2018)Doi:10.1016/j.tetlet.2008.02.064
(2008)Doi:10.1080/00397910008087049
(2000)